Fabius, I have to concur somewhat with wim. Regabatin may not be dead but it may as well be. what Dog found was great but it shows us more of the same.
Odidi has spent the last 2 years on research and patents. Thats it. Rexista was filed, and as we found out could have been filed with the same information 2 years earlier.
Odidi has used the last 2 years and capital raises to do nothing but further his research and apply for patents. He is either unable or unwilling to partner. My guess is the latter.
The company held the IND for Regabatin in 2015 and was given direction. It was after this direction the company announced they will need to partner the drug because of the enormous cost and trials required. My guess is, he had suitors but turned them down thinking his "technology" was worth more than they were willing to pay. so what does he do? he goes back to enhance the patents to improve them, thinking it will bolster his position.
what happened was he, and we, were left behind in a sail boat waiting on the wind while others were in power boats leaving us behind.
The fact is its great to improve the patents but we are still stuck with the issue that Regabatin goes nowhere without a partner. Now what has happened, Pfizer came out with their own ER Lyrica and Lyrica goes off patent next year. which means Regabatin will have to compete with Generics and Pfizer will automatically sue IPCI for patent infringement even when IPCI does file the application for Regabatin. why? because that is another way to stall Regabatin just like Purdue is doing with Rexista and keep the competition at bay for another 2 years. It wont matter that IPCI has mutiple patents. is just means they will win at trail. The other party still gets to file their lawsuit and hold things up until they can prove their innocence. its what big pharmas do.
so that brings us to the reality. Regabatin is easily 7 years out. once they partner it, they have 2 to 3 years of trails, another year to file application and another 1.5 year to get through the court system and then hopefully, no refiling issue but then another 1 year gain final approval. Now you say that doesnt equal 7 years. No it does not, but we haven't signed a deal yet have we. My guess is he can only do 1 thing at a time and it will be 2 years until we finally settle Rexista and get back through the FDA and partner it and get up and running and THEN he will go to Regabatin.
